Fermer le menu


Member of Lyonbiopole


AUROBAC THERAPEUTICS is a biopharmaceutical company created in 2022 by 3 renowned life sciences innovation companies, Boehringer Ingelheim, Evotec and bioMérieux, to become a global leader in the fight against bacterial infections, Antimicrobial Resistance (AMR) and their consequences in acute hospital settings.

We focus our efforts to develop the next generation of antimicrobial and acute care products, following a targeted precision medicine approach, i.e. associated with rapid diagnostics to support product use.


Application market: Infectious Diseases

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Others

Created on nov. 10th, 2021 - 10 employees



29 Avenue Tony Garnier 69007 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.